mutation predictions | marginal predictions | summary statistics | genome diff | command line log
|
breseq version 0.35.4 revision f352f80f4bc9
mutation predictions | marginal predictions | summary statistics | genome diff | command line log |
| Marginal read alignment evidence (highest frequency 20 of 29 shown, sorted by frequency from high to low) | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| seq id | position | ref | new | freq | score (cons/poly) | reads | annotation | genes | product | ||
| * | NZ_CP009273 | 3,748,723 | 0 | A | C | 62.5% | 7.6 / 14.8 | 16 | G383G (GGT→GGG) | aldB | aldehyde dehydrogenase AldB |
| * | NZ_CP009273 | 2,153,677 | 0 | T | G | 61.5% | 7.6 / 10.8 | 15 | V604G (GTG→GGG) | mdtC | multidrug efflux RND transporter permease subunit MdtC |
| * | NZ_CP009273 | 3,588,404 | 0 | T | A | 61.1% | ‑2.0 / 18.9 | 18 | Y146F (TAC→TTC) | livM | branched chain amino acid ABC transporter permease LivM |
| * | NZ_CP009273 | 2,319,929 | 0 | T | G | 60.0% | ‑0.5 / 15.6 | 15 | G114G (GGT→GGG) | atoB | acetyl‑CoA acetyltransferase |
| * | NZ_CP009273 | 4,594,161 | 0 | C | T | 60.0% | ‑1.5 / 31.8 | 30 | S62F (TCT→TTT) | bglJ | DNA‑binding transcriptional activator BglJ |
| * | NZ_CP009273 | 4,594,167 | 0 | C | T | 60.0% | 0.9 / 30.2 | 30 | S64F (TCT→TTT) | bglJ | DNA‑binding transcriptional activator BglJ |
| * | NZ_CP009273 | 3,055,679 | 0 | A | C | 58.3% | 7.2 / 10.9 | 12 | T491P (ACC→CCC) | scpA | methylmalonyl‑CoA mutase |
| * | NZ_CP009273 | 3,124,782 | 0 | G | C | 58.3% | 5.6 / 12.9 | 12 | pseudogene (986/1065 nt) | yghQ | lipopolysaccharide biosynthesis protein |
| * | NZ_CP009273 | 3,775,371 | 0 | A | C | 58.3% | 9.4 / 12.5 | 12 | G184G (GGT→GGG) | cysE | serine O‑acetyltransferase |
| * | NZ_CP009273 | 2,290,243 | 0 | T | G | 57.1% | 10.4 / 16.4 | 14 | L87F (TTA→TTC) | ccmB | heme exporter protein CcmB |
| * | NZ_CP009273 | 2,336,778 | 0 | T | A | 57.1% | 0.2 / 11.5 | 14 | M291L (ATG→TTG) | yfaL | AIDA‑I family autotransporter adhesin YfaL/EhaC |
| * | NZ_CP009273 | 2,343,100 | 0 | A | C | 57.1% | 2.5 / 10.2 | 14 | pseudogene (36/105 nt) | BW25113_RS26180 | hypothetical protein |
| * | NZ_CP009273 | 4,612,067 | 0 | A | G | 56.5% | 7.2 / 22.7 | 23 | E161G (GAG→GGG) | yjjJ | type II toxin‑antitoxin system HipA family toxin YjjJ |
| * | NZ_CP009273 | 3,578,446 | 0 | A | C | 56.2% | 5.4 / 18.8 | 16 | Y580D (TAC→GAC) | ggt | gamma‑glutamyltransferase |
| * | NZ_CP009273 | 382,920 | 0 | T | G | 54.5% | 4.1 / 10.0 | 11 | V165G (GTG→GGG) | tauC | taurine ABC transporter permease TauC |
| * | NZ_CP009273 | 762,137 | 0 | C | G | 54.5% | 8.9 / 14.8 | 11 | A213G (GCG→GGG) | mngA | PTS 2‑O‑a‑mannosyl‑D‑glycerate transporter subunit IIABC |
| * | NZ_CP009273 | 3,294,154 | 0 | G | T | 54.5% | 3.7 / 14.6 | 11 | T161N (ACC→AAC) | ubiT | SCP2 domain‑containing protein |
| * | NZ_CP009273 | 4,527,926 | 0 | A | C | 54.5% | 5.1 / 11.4 | 11 | G219G (GGT→GGG) | nanM | N‑acetylneuraminate epimerase |
| * | NZ_CP009273 | 172,103 | 0 | T | G | 54.2% | 15.1 / 29.9 | 24 | G170G (GGT→GGG) | clcA | H(+)/Cl(‑) exchange transporter ClcA |
| * | NZ_CP009273 | 4,501,865 | 0 | A | C | 54.2% | 13.0 / 24.1 | 24 | L123V (TTG→GTG) | fecD | Fe(3+) dicitrate ABC transporter permease subunit FecD |